Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
Identifieur interne : 001A93 ( Main/Exploration ); précédent : 001A92; suivant : 001A94Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
Auteurs : A. M. Bertoli [Porto Rico] ; L. M. Vila [États-Unis] ; M. Apte [États-Unis] ; B. J. Fessler [États-Unis] ; H. M. Bastian [États-Unis] ; J. D. Reveille [États-Unis] ; G. S. Alarcon [États-Unis]Source :
- Lupus [ 0961-2033 ] ; 2007-06.
English descriptors
- Teeft :
- Acute event, Acute pneumonitis, Alveolar hemorrhage, American college, Arthritis rheum, Bertoli, Brosis, Clin, Clinical manifestations, Clinics damage index, Cohort, Disease activity, Disease duration, Erythematosus, Ethnic groups, Glucocorticoid, Higher scores, Hypertension, Lumen, Lumina cohort, Lumina database, Lumina patients, Luminaa patients, Lupus, Lupus erythematosus, Manifestation, Oral ulcers, Organ damage, Pneumonitis, Psychological variables, Puerto rico, Pulmonary damage, Pulmonary domain, Pulmonary hypertension, Pulmonary infarction, Regression analysis, Rheum, Rheumatol, Rheumatology, Rheumatology damage index, Risk factors, Sciences campus, Shorter time, Social support, Survival curve, Systemic, Systemic lupus, Systemic lupus erythematosus, Univariable.
Abstract
The objective of this study was to determine the factors predictive of time to the occurrence of pulmonary damage in systemic lupus erythematosus (SLE). Six-hundred and twenty-six SLE patients from a multiethnic (Hispanics, African Americans and Caucasians) longitudinal study of outcome were studied. Pulmonary damage was defined as per the Systemic Lupus International Collaborating Clinics Damage Index. Socioeconomic-demographic, clinical, genetic, serological features, pharmacologic treatments, behavioural, psychological and disease activity [as per the Systemic Lupus Activity Measure-Revised (SLAM-R)] were examined. Factors associated with time to the occurrence of pulmonary damage were examined by Cox proportional hazards regressions. A Kaplan—Meier survival curve was also examined. Forty-six (7.3%) patients had pulmonary damage after a mean (SD) total disease duration of 5.3 (3.6) years. Among those patients, 25 had pulmonary fibrosis, 12 pulmonary hypertension, eight pleural fibrosis, four pulmonary infarction and four shrinking lung syndrome. Seven patients had more than one type of lung damage. Cumulative rates of pulmonary damage at five and 10 years were 7.6% and 11.6%, respectively. In the multivariable analyses, age (HR = 1.033, 95% CI 1.006—1.060; P = 0.0170), pneumonitis (HR = 2.307, 95% CI 1.123—4.739; P = 0.0229) and anti-RNP antibodies (HR = 2.344, 95% CI 1.190—4.618; P = 0.0138) were associated with a shorter time to the occurrence of pulmonary damage while photosensitivity (HR = 0.388, 95% CI 0.184—0.818; P = 0.0128) and oral ulcers (HR = 0.466, 95% CI 0.230—0.942; P = 0.0335) with a longer time. Pulmonary damage is relatively common in SLE. Age, pneumonitis and anti-RNP antibodies were associated with a shorter time to the development of permanent lung disease. Lupus (2007) 16, 410—417.
Url:
DOI: 10.1177/0961203307079042
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C53
- to stream Istex, to step Curation: 001C53
- to stream Istex, to step Checkpoint: 000976
- to stream Main, to step Merge: 001B04
- to stream Main, to step Curation: 001A93
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage</title><author wicri:is="90%"><name sortKey="Bertoli, A M" sort="Bertoli, A M" uniqKey="Bertoli A" first="A. M." last="Bertoli">A. M. Bertoli</name></author><author wicri:is="90%"><name sortKey="Vila, L M" sort="Vila, L M" uniqKey="Vila L" first="L. M." last="Vila">L. M. Vila</name></author><author wicri:is="90%"><name sortKey="Apte, M" sort="Apte, M" uniqKey="Apte M" first="M." last="Apte">M. Apte</name></author><author wicri:is="90%"><name sortKey="Fessler, B J" sort="Fessler, B J" uniqKey="Fessler B" first="B. J." last="Fessler">B. J. Fessler</name></author><author wicri:is="90%"><name sortKey="Bastian, H M" sort="Bastian, H M" uniqKey="Bastian H" first="H. M." last="Bastian">H. M. Bastian</name></author><author wicri:is="90%"><name sortKey="Reveille, J D" sort="Reveille, J D" uniqKey="Reveille J" first="J. D." last="Reveille">J. D. Reveille</name></author><author wicri:is="90%"><name sortKey="Alarcon, G S" sort="Alarcon, G S" uniqKey="Alarcon G" first="G. S." last="Alarcon">G. S. Alarcon</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8978175FCCE6B066D4BCB998F141F844F855A2A4</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1177/0961203307079042</idno><idno type="url">https://api.istex.fr/ark:/67375/M70-8MJ4VRK1-D/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001C53</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C53</idno><idno type="wicri:Area/Istex/Curation">001C53</idno><idno type="wicri:Area/Istex/Checkpoint">000976</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000976</idno><idno type="wicri:doubleKey">0961-2033:2007:Bertoli A:systemic:lupus:erythematosus</idno><idno type="wicri:Area/Main/Merge">001B04</idno><idno type="wicri:Area/Main/Curation">001A93</idno><idno type="wicri:Area/Main/Exploration">001A93</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage</title><author wicri:is="90%"><name sortKey="Bertoli, A M" sort="Bertoli, A M" uniqKey="Bertoli A" first="A. M." last="Bertoli">A. M. Bertoli</name><affiliation wicri:level="1"><country xml:lang="fr">Porto Rico</country><wicri:regionArea>Department of Medicine (Division of Rheumatology), The University of Puerto Rico Medical Sciences Campus, San Juan</wicri:regionArea><wicri:noRegion>San Juan</wicri:noRegion></affiliation></author><author wicri:is="90%"><name sortKey="Vila, L M" sort="Vila, L M" uniqKey="Vila L" first="L. M." last="Vila">L. M. Vila</name><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author><author wicri:is="90%"><name sortKey="Apte, M" sort="Apte, M" uniqKey="Apte M" first="M." last="Apte">M. Apte</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>Department of Medicine (Division of Clinical Immunology and Rheumatology), School of Medicine, The University of Alabama at Birmingham, Birmingham</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Fessler, B J" sort="Fessler, B J" uniqKey="Fessler B" first="B. J." last="Fessler">B. J. Fessler</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>Department of Medicine (Division of Clinical Immunology and Rheumatology), School of Medicine, The University of Alabama at Birmingham, Birmingham</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Bastian, H M" sort="Bastian, H M" uniqKey="Bastian H" first="H. M." last="Bastian">H. M. Bastian</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>Department of Medicine (Division of Clinical Immunology and Rheumatology), School of Medicine, The University of Alabama at Birmingham, Birmingham</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Reveille, J D" sort="Reveille, J D" uniqKey="Reveille J" first="J. D." last="Reveille">J. D. Reveille</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Department of Medicine (Division of Rheumatology), The University of Texas Health Science Center at Houston, Houston</wicri:cityArea></affiliation></author><author wicri:is="90%"><name sortKey="Alarcon, G S" sort="Alarcon, G S" uniqKey="Alarcon G" first="G. S." last="Alarcon">G. S. Alarcon</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>Department of Medicine (Division of Clinical Immunology and Rheumatology), School of Medicine, The University of Alabama at Birmingham, Birmingham</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Lupus</title><idno type="ISSN">0961-2033</idno><idno type="eISSN">1477-0962</idno><imprint><publisher>Sage Publications</publisher><pubPlace>Sage UK: London, England</pubPlace><date type="published" when="2007-06">2007-06</date><biblScope unit="volume">16</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="410">410</biblScope><biblScope unit="page" to="417">417</biblScope></imprint><idno type="ISSN">0961-2033</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0961-2033</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute event</term><term>Acute pneumonitis</term><term>Alveolar hemorrhage</term><term>American college</term><term>Arthritis rheum</term><term>Bertoli</term><term>Brosis</term><term>Clin</term><term>Clinical manifestations</term><term>Clinics damage index</term><term>Cohort</term><term>Disease activity</term><term>Disease duration</term><term>Erythematosus</term><term>Ethnic groups</term><term>Glucocorticoid</term><term>Higher scores</term><term>Hypertension</term><term>Lumen</term><term>Lumina cohort</term><term>Lumina database</term><term>Lumina patients</term><term>Luminaa patients</term><term>Lupus</term><term>Lupus erythematosus</term><term>Manifestation</term><term>Oral ulcers</term><term>Organ damage</term><term>Pneumonitis</term><term>Psychological variables</term><term>Puerto rico</term><term>Pulmonary damage</term><term>Pulmonary domain</term><term>Pulmonary hypertension</term><term>Pulmonary infarction</term><term>Regression analysis</term><term>Rheum</term><term>Rheumatol</term><term>Rheumatology</term><term>Rheumatology damage index</term><term>Risk factors</term><term>Sciences campus</term><term>Shorter time</term><term>Social support</term><term>Survival curve</term><term>Systemic</term><term>Systemic lupus</term><term>Systemic lupus erythematosus</term><term>Univariable</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to determine the factors predictive of time to the occurrence of pulmonary damage in systemic lupus erythematosus (SLE). Six-hundred and twenty-six SLE patients from a multiethnic (Hispanics, African Americans and Caucasians) longitudinal study of outcome were studied. Pulmonary damage was defined as per the Systemic Lupus International Collaborating Clinics Damage Index. Socioeconomic-demographic, clinical, genetic, serological features, pharmacologic treatments, behavioural, psychological and disease activity [as per the Systemic Lupus Activity Measure-Revised (SLAM-R)] were examined. Factors associated with time to the occurrence of pulmonary damage were examined by Cox proportional hazards regressions. A Kaplan—Meier survival curve was also examined. Forty-six (7.3%) patients had pulmonary damage after a mean (SD) total disease duration of 5.3 (3.6) years. Among those patients, 25 had pulmonary fibrosis, 12 pulmonary hypertension, eight pleural fibrosis, four pulmonary infarction and four shrinking lung syndrome. Seven patients had more than one type of lung damage. Cumulative rates of pulmonary damage at five and 10 years were 7.6% and 11.6%, respectively. In the multivariable analyses, age (HR = 1.033, 95% CI 1.006—1.060; P = 0.0170), pneumonitis (HR = 2.307, 95% CI 1.123—4.739; P = 0.0229) and anti-RNP antibodies (HR = 2.344, 95% CI 1.190—4.618; P = 0.0138) were associated with a shorter time to the occurrence of pulmonary damage while photosensitivity (HR = 0.388, 95% CI 0.184—0.818; P = 0.0128) and oral ulcers (HR = 0.466, 95% CI 0.230—0.942; P = 0.0335) with a longer time. Pulmonary damage is relatively common in SLE. Age, pneumonitis and anti-RNP antibodies were associated with a shorter time to the development of permanent lung disease. Lupus (2007) 16, 410—417.</div></front></TEI><affiliations><list><country><li>Porto Rico</li><li>États-Unis</li></country><region><li>Alabama</li><li>Texas</li></region></list><tree><country name="Porto Rico"><noRegion><name sortKey="Bertoli, A M" sort="Bertoli, A M" uniqKey="Bertoli A" first="A. M." last="Bertoli">A. M. Bertoli</name></noRegion></country><country name="États-Unis"><noRegion><name sortKey="Vila, L M" sort="Vila, L M" uniqKey="Vila L" first="L. M." last="Vila">L. M. Vila</name></noRegion><name sortKey="Alarcon, G S" sort="Alarcon, G S" uniqKey="Alarcon G" first="G. S." last="Alarcon">G. S. Alarcon</name><name sortKey="Apte, M" sort="Apte, M" uniqKey="Apte M" first="M." last="Apte">M. Apte</name><name sortKey="Bastian, H M" sort="Bastian, H M" uniqKey="Bastian H" first="H. M." last="Bastian">H. M. Bastian</name><name sortKey="Fessler, B J" sort="Fessler, B J" uniqKey="Fessler B" first="B. J." last="Fessler">B. J. Fessler</name><name sortKey="Reveille, J D" sort="Reveille, J D" uniqKey="Reveille J" first="J. D." last="Reveille">J. D. Reveille</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8978175FCCE6B066D4BCB998F141F844F855A2A4
|texte= Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
}}
| This area was generated with Dilib version V0.6.33. |  |